SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-009337
Filing Date
2010-11-05
Accepted
2010-11-05 17:27:17
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2200781z10-q.htm 10-Q 1716653
2 EXHIBIT 31.1 a2200781zex-31_1.htm EX-31.1 8707
3 EXHIBIT 31.2 a2200781zex-31_2.htm EX-31.2 8768
4 EXHIBIT 32.1 a2200781zex-32_1.htm EX-32.1 5691
5 EXHIBIT 32.2 a2200781zex-32_2.htm EX-32.2 5740
  Complete submission text file 0001047469-10-009337.txt   6055761

Data Files

Seq Description Document Type Size
6 EX-101.INS vrx-20100930.xml EX-101.INS 849754
7 EX-101.SCH vrx-20100930.xsd EX-101.SCH 34752
8 EX-101.CAL vrx-20100930_cal.xml EX-101.CAL 60355
9 EX-101.LAB vrx-20100930_lab.xml EX-101.LAB 381805
10 EX-101.PRE vrx-20100930_pre.xml EX-101.PRE 160524
11 EX-101.DEF vrx-20100930_def.xml EX-101.DEF 108279
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 101169836
SIC: 2834 Pharmaceutical Preparations